Tanguay S - Search Results

1

Navigating Focal Therapy for Prostate Cancer: Contemporary Perspectives and Future Trajectories in the Canadian Context.

Hesswani C, Avolio PP, Rompre-Brodeur A, Ghai S, Anidjar M, Kinnaird A, Chin J, Perlis N, Soytas M, Mannas M, Ahmad A, Klotz L, Tanguay S, Kassouf W, McPherson V, Aprikian A, Pinto P, Sanchez-Salas R. Hesswani C, et al. Among authors: tanguay s. J Endourol. 2024 Nov 29. doi: 10.1089/end.2024.0619. Online ahead of print. J Endourol. 2024. PMID: 39612186

2

Thirty-day mortality rates and cumulative survival after radical retropubic prostatectomy.

Karakiewicz PI, Bazinet M, Aprikian AG, Tanguay S, Elhilali MM. Karakiewicz PI, et al. Among authors: tanguay s. Urology. 1998 Dec;52(6):1041-6. doi: 10.1016/s0090-4295(98)00350-1. Urology. 1998. PMID: 9836552

3

Links between Fer tyrosine kinase expression levels and prostate cell proliferation.

Allard P, Zoubeidi A, Nguyen LT, Tessier S, Tanguay S, Chevrette M, Aprikian A, Chevalier S. Allard P, et al. Among authors: tanguay s. Mol Cell Endocrinol. 2000 Jan 25;159(1-2):63-77. doi: 10.1016/s0303-7207(99)00205-1. Mol Cell Endocrinol. 2000. PMID: 10687853

4

The evolving role of radical surgery in the management of regionally advanced transitional cell carcinoma of the bladder.

Aprikian AG, Tanguay S. Aprikian AG, et al. Among authors: tanguay s. Can J Urol. 1998 Dec;5(5):643-651. Can J Urol. 1998. PMID: 11319040

5

Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection.

Tanguay S, Bégin LR, Elhilali MM, Behlouli H, Karakiewicz PI, Aprikian AG. Tanguay S, et al. Urology. 2002 Feb;59(2):261-5. doi: 10.1016/s0090-4295(01)01497-2. Urology. 2002. PMID: 11834399

6

Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer.

Stephenson AJ, Aprikian AG, Souhami L, Behlouli H, Jacobson AI, Bégin LR, Tanguay S. Stephenson AJ, et al. Among authors: tanguay s. Urology. 2002 May;59(5):652-6. doi: 10.1016/s0090-4295(02)01526-1. Urology. 2002. PMID: 11992834

7

Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 for prostate cancer detection in patients undergoing prostate biopsy.

Ismail A H, Pollak M, Behlouli H, Tanguay S, Begin LR, Aprikian AG. Ismail A H, et al. Among authors: tanguay s. J Urol. 2002 Dec;168(6):2426-30. doi: 10.1016/S0022-5347(05)64160-2. J Urol. 2002. PMID: 12441932

8

Familial prostate and breast cancer in men treated with prostatectomy for prostate cancer: a population based case-control study.

Karakiewicz PI, Foulkes W, Tanguay S, Elhilali M, Aprikian AG. Karakiewicz PI, et al. Among authors: tanguay s. J Urol. 2003 Jan;169(1):240-4. doi: 10.1016/S0022-5347(05)64077-3. J Urol. 2003. PMID: 12478145

9

Cross-cultural validation of the UCLA prostate cancer index.

Karakiewicz PI, Kattan MW, Tanguay S, Elhilali MM, Bazinet M, Scardino PT, Aprikian AG. Karakiewicz PI, et al. Among authors: tanguay s. Urology. 2003 Feb;61(2):302-7. doi: 10.1016/s0090-4295(02)02245-8. Urology. 2003. PMID: 12597935

10

Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails.

Kassouf W, Tanguay S, Aprikian AG. Kassouf W, et al. Among authors: tanguay s. J Urol. 2003 May;169(5):1742-4. doi: 10.1097/01.ju.0000057795.97626.66. J Urol. 2003. PMID: 12686822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters